Skip to main content

HEALTH

  • BMS donates grants to help African-American women fight Type 2 diabetes

    NEW YORK — The charitable arm of Bristol-Myers Squibb has awarded five grants totaling $1.5 million to organizations that encourage African-American women with Type 2 diabetes to better manage their disease.

  • Xlear unveils nasal spray products for adults, kids

    OREM, Utah — Xlear recently announced the release of two new products: Xlear nasal spray and Kids Xlear nasal spray.

    The new Xlear nasal sprays are formulated with xylitol, a 5-carbon sugar alcohol found in many fruits and vegetables. The Kids Xlear nasal spray retails for approximately $6.99. The adult version of Xlear nasal spray retails for $6.99 and also is available in an easy-to-inhale “Pump-Mist” dispenser, retailing for $13.49.

  • Prestige Brands expands sales management, customer planning departments

    NEW YORK — Prestige Brands has expanded its sales management team and customer planning group.

    The appointments include:

    • David Howenstine, who joins Prestige as VP sales from Pfizer. At Pfizer, he served in a variety of leadership roles in field sales, customer development and category management;

    • Jayne Reiss, who previously worked at Warner Lambert, Brach, Insight Pharmaceutical and Matrixx, where she managed the national accounts sales force, has joined Prestige as VP national accounts;

  • Intimina by Lelo caters to feminine wellness

    SAN JOSE, Calif. — Lelo on Thursday launched Intimina by Lelo, a new brand of intimate wellness products positioned as a premium to what’s on the shelf today.

    The new line of products — a line of personal massagers, pelvic floor exercisers, hygienic cleansers and feminine moisturizers — will be available to ship this summer.

  • Diabetic kidney disease on rise in United States

    NEW YORK — Despite the expansion of the diabetes drug market over the past 20 years, the rate of diabetic kidney disease has become more prevalent in the United States.

  • Intensive-dose statin therapy may pose higher diabetes risk among patients

    NEW YORK — It seems that intensive-dose statin therapy is linked with a higher risk of onset diabetes, compared with moderate-dose therapy, according to an analysis published in the Journal of the American Medical Association.

    The analysis, which pooled data from previously published clinical trials, found that among 32,752 nondiabetic participants:

    • 2,749 participants (8.4%) developed diabetes. Among them, 1,449 were assigned intensive-dose therapy, while 1,300 assigned moderate-dose therapy;

  • Senokot products tout new packaging

    NEW YORK — Purdue Products on Thursday announced new packaging and product design across its Senokot Laxatives Comfort Promise line.

    The packaging makeover includes Senokot-S Tablets, a laxative plus stool softener for those who experience occasional constipation which may be caused by certain medications, and Senokot To Go, a convenient, easy-to-carry four-pack choice for busy consumers with on-the-go schedules.

  • Adding PycnoQ10 to treatment for heart failure patients boosts blood flow to organs

    HOBOKEN, N.J. — A recent study published in Panminerva Medica found that a pycnogenol and coenzyme-Q10 combination (PycnoQ10) taken by stable heart failure patients as an adjunct to medical treatment naturally strengthens the heart, increasing the blood volume ejected with each beat.

    As a result, the oxygen-rich blood supply to the organs improves, and patients become more physically energetic.

    Pycnogenol is an antioxidant plant extract from the bark of the French maritime pine tree and has been clinically proven to improve endothelial function and blood flow.

X
This ad will auto-close in 10 seconds